Cas No.: | 779356-64-8 |
Chemical Name: | methylN-[6-[4-[[(2S)-2-aminopropanoyl]amino]phenyl]sulfanyl-1H-benzimidazol-2-yl]carbamate;hydrochloride |
Synonyms: | MN-029,MN029,MN 029 |
SMILES: | O=C(OC)NC1=NC2=CC(SC3=CC=C(NC([C@@H](N)C)=O)C=C3)=CC=C2N1.[H]Cl |
Formula: | C18H20ClN5O3S |
M.Wt: | 421.9011 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | MN-029 (denibulin HCl) is a novel vascular-disrupting agent that reversibly inhibits microtubule assembly, resulting in disruption of the cytoskeleton of tumor vascular endothelial cells. For the detailed information of Denibulin (MN-029), the solubility of Denibulin (MN-029) in water, the solubility of Denibulin (MN-029) in DMSO, the solubility of Denibulin (MN-029) in PBS buffer, the animal experiment (test) of Denibulin (MN-029), the cell expriment (test) of Denibulin (MN-029), the in vivo, in vitro and clinical trial test of Denibulin (MN-029), the EC50, IC50,and Affinity of Denibulin (MN-029), Please contact DC Chemicals. |